genomics


There is no doubt that the interest and hype around blockchain, or distributed ledger technology (DLT), builds daily. The explosion of articles and books recently is testament to this. But what is a blockchain and how might distributed ledger technology impact healthcare, Pharma and R&D? In a new article on pages 52-57 of the Fall […]

Blockchain Technology in Drug Discovery: Use Cases in R&D.


Here at Curlew Research we are very interested in the potential offered by blockchain, also known as distributed ledger technology (DLT), to advance, enhance and disrupt healthcare – from candidate drug discovery to the medicines supply chain.  One area that seems to us ripe for the marriage of DLT and healthcare is genomics – specifically […]

Curlew Research Partner, Encrypgen Interviewed By Forbes.com


4
We are delighted to announce that Curlew Research will be leading a conference workshop at BioIT World Expo on May 23rd 2017– “An Intro To Blockchain In Life Science“. Blockchain technology, also known as “distributed ledger technology” (DLT) is currently one of the hottest tech items around. Every day, blockchain is being touted as a […]

Curlew Research Leading Workshop On Blockchain at BioIT World Expo, ...